References
- Hajto T., Hostanska K., Saller R. Mistletoe therapy from the pharmacologic perspective. Forsch Komplementarmed 1999; 6: 189–194
- Elsasser-Beile U., Lusebrink S., Grussenmeyer T., Wetterauer U., Schultze-Seemann W. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes. Arzneimittelforschung 1998; 48: 1185–1189
- Mengs U., Witthohn K., Schwarz T., Lentzen H. Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties. Wien Med. Wochenschr 1999; 149: 262–4
- Stein G. M., Schietzel M., Bussing A. Mistletoe in immunology and the clinic (short review). Anticancer Res. 1998; 18: 3247–3249
- Lenartz D., Andermahr 1, Plum G., Menzel J., Beuth J. Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma. Anticancer Res. 1998; 18: 1011–1014
- Yoon T. J., Yoo Y. C., Kang T. B., Shimazaki K., Song S. K., Lee K. H., Kim S. H., Park C. H., Azuma I., Kim I. B. Lectins isolated from Korean mistletoe (Viscum album color-atum) induce apoptosis in tumor cells. Cancer Lett. 1999; 136: 33–40
- Eck J., Langer M., Mockel B., Witthohn K., Zinke H., Lentzen H. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur. J. Biochem. 1999; 265: 788–797
- Szatmaty Z. Tumor necrosis factor-alpha: molecular-biological aspects minireview. Neoplasma 1999; 46: 257–266
- Read R. C. Experimental therapies for sepsis directed against tumour necrosis factor. J. Antimicrob. Chemother. 1998; 41: 65–69
- Jones B. E., Lo C. R., Liu H., Srinivasan A., Streetz K., Valentino K. L., Czaja M. J. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J. Biol. Chem. 2000; 275: 705–712
- Lee H. S., Kim Y. S., Kim S. B., Choi B. E., Woo B. H., Lee K. C. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Color-atum. Cell. Mol. Life Sci. 1999; 55: 679–682
- Pae H. O., Yoo J. C., Choi B. M., Kang C. L., Kim J. D., Chung H. T. Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells. Immunopharmacol. Immunotoxicol. 1999; 21: 667–82
- Beuth J., Ko H. L., Gabius H. J., Pulverer G. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. In Vivo 1991; 5: 29–32
- Hajto T., Hostanska K., Gabius H. J. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. 1989; 49: 4803–4808
- Langer M., Mockel B., Eck J., Zinke H., Lentzen H. Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis. Biochem. Biophys. Res. Commun. 1999; 264: 944–948
- Ribereau-Gayon G., Dumont S., Muller C., Jung M. L., Poin-Dron P., Anton R. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 1996; 33–38
- Luster M. L, Simeonova P. P., Gallucci R., Matheson J. Tumor necrosis factor alpha and toxicology. Crit. Rev. Toxicol. 1999; 29: 491–511
- Martin S. I. Apoptosis: suicide, execution or murder. Trends Cell Biol. 1993; 3: 141–144